comparemela.com

Latest Breaking News On - Binod dhakal - Page 5 : comparemela.com

ASCO 2023: Ground-Breaking Results With CAR T-Cell Therapies

Studies of CAR T-cell therapies presented at ASCO 2023 broke new ground and may change practice, according to researchers.

United statesBinod dhakalAl hadidiJason westinCollege of wisconsinUniversity of texas md anderson cancer centerSecond line treatmentCancer centerCilta cel could be used earlierMedical college

ASCO 2023: Studies Clarify Role of Immunotherapy in Multiple Myeloma

Studies from ASCO 2023 revealed new potential standards of care for multiple myeloma and a first for bispecific antibody therapy.

University medical centerUnited statesBinod dhakalPp binod dhakalJoseph mikhaelStefan knopTranslational genomics research instituteCollege of wisconsinInternational myeloma foundationCilta cel improvedMedical collegeElotuzumab improved upon

ASCO 2023: Studies Clarify Role of Immunotherapy in Multiple Myeloma

Studies from ASCO 2023 revealed new potential standards of care for multiple myeloma and a first for bispecific antibody therapy.

University medical centerUnited statesPp binod dhakalStefan knopBinod dhakalJoseph mikhaelInternational myeloma foundationTranslational genomics research instituteCollege of wisconsinCilta cel improvedMedical collegeElotuzumab improved upon

Cilta-Cel May Be New Standard Care for Lenalidomide-Refractory MM

Cilta-cel outperformed standard care in patients with lenalidomide-refractory multiple myeloma in the CARTITUDE-4 trial.

Binod dhakalJanssen research developmentCollege of wisconsinMedical collegeJanssen research

Breakthrough in treating one of the deadliest cancers

Presenting their findings at the American Society of Clinical Oncology, the experts said the treatment offers a potential new standard of care for patients with limited options left.

United statesUnited kingdomBinod dhakalCollege of wisconsinAmerican society of clinical oncologyCancer research united kingdomMedical collegeAmerican societyClinical oncology

vimarsana © 2020. All Rights Reserved.